Abiomed, Inc. (ABMD) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Abiomed, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
110.41
Weak
WeakModerateStrong
P/B Ratio
10.01
Weak
WeakModerateStrong
Earnings Yield
0.91%
Yield Trap
WeakModerateStrong
Profitability Health
TTMReturn on Equity
9.08%
Weak
WeakModerateStrong
Operating Margin
36.12%
Strong
WeakModerateStrong
Net Profit Margin
13.23%
Moderate
WeakModerateStrong
Efficiency & Liquidity
TTMCurrent Ratio
7.05
Strong
WeakModerateStrong
Quick Ratio
6.37
Strong
WeakModerateStrong
Asset Turnover
0.62x
Moderate
WeakModerateStrong
Inventory Turnover
2.00x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
1.66%
Weak
WeakModerateStrong
EV / Free Cash Flow
59.77x
Weak
WeakModerateStrong
Net Debt / EBITDA
-0.27x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.511
Weak
WeakModerateStrong
Return on Invested Capital
17.39%
Moderate
WeakModerateStrong
Cash Conversion Cycle
145.80 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ABMD.
View Financial Statements